These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Aspects of chronic oral treatment with thyrotropin-releasing hormone: the hypothalamic-pituitary-thyroid axis in rats. A study with a pharmacological dose of thyrotropin-releasing hormone. Duntas L, Roussel JP, Astier H, Keck FS, Rosenthal J, Pfeiffer EF. Pharmacology; 1991; 43(2):106-12. PubMed ID: 1775509 [Abstract] [Full Text] [Related]
24. Serum calcium decline after intravenous administration of thyrotropin-releasing hormone in man. Röjdmark S, Andersson DE, Edström E, Lamminpää K. Horm Metab Res; 1983 Jun; 15(6):290-3. PubMed ID: 6409774 [Abstract] [Full Text] [Related]
28. Determination of serum calcitonin by immunometric two-site assays in normal subjects and patients with medullary thyroid carcinoma. Zink A, Blind E, Raue F. Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):831-5. PubMed ID: 1489858 [Abstract] [Full Text] [Related]
30. Comparison of serum calcitonin levels after a 1-minute calcium injection and after pentagastrin injection in the diagnosis of medullary thyroid carcinoma. Rude RK, Singer FR. J Clin Endocrinol Metab; 1977 May; 44(5):980-3. PubMed ID: 858780 [Abstract] [Full Text] [Related]
31. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker. Marrinan M, Skrabanek P, Moriarty M, McPartlin J, Powell D. Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727 [Abstract] [Full Text] [Related]
32. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. Barbot N, Calmettes C, Schuffenecker I, Saint-André JP, Franc B, Rohmer V, Jallet P, Bigorgne JC. J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611 [Abstract] [Full Text] [Related]
34. Calcitonin in plasma and cerebrospinal fluid from normal subjects and patients with medullary thyroid carcinoma: possible restriction of calcitonin by the blood-brain barrier. Morimoto S, Nishimura J, Miyauchi A, Takai S, Okada Y, Onishi T, Fukuo K, Lee S, Kumahara Y. J Clin Endocrinol Metab; 1982 Sep; 55(3):594-6. PubMed ID: 7096542 [Abstract] [Full Text] [Related]
36. [Effect of calcitonin on secretion of TSH stimulated by giving thyroliberin (TRH) in euthyroid subjects]. Gasińska T, Nowak S, Kierat A. Endokrynol Pol; 1992 Sep; 43(1):47-53. PubMed ID: 1345525 [Abstract] [Full Text] [Related]
37. Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid. Lee S, Morimoto S, Onishi T, Tsuji M, Okada Y, Seino Y, Ishida M, Yamaoka K, Takai S, Miyauchi A, Kumahara Y. J Clin Endocrinol Metab; 1982 Aug; 55(2):361-3. PubMed ID: 6979551 [Abstract] [Full Text] [Related]